Skip to content

Clinical trials

Phase 3 Osteoporosis trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Osteoporosis Phase: Phase 3 Country / region: Germany Clear all

17 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20012
20022
20041
20051
20065
20071
20081
20101
20123

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed14
Terminated3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis5
Novartis Pharmaceuticals5
Amgen2
Eli Lilly and Company1
Evangelisches Krankenhaus Lutherhaus gGmbH1
Ligand Pharmaceuticals1
Pfizer1
University of Erlangen-Nürnberg Medical School1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Osteoporosis17
Bone Diseases, Metabolic4
Osteoporosis, Postmenopausal3
Bone Diseases2
Musculoskeletal Diseases2
Atrophy1
Breast Neoplasms1
Cardiovascular Diseases1
Diabetes Mellitus1
Fractures, Bone1

Trials

Showing 1 to 17 of 17. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.